ORIGINAL RESEARCH article
Front. Oncol.
Sec. Breast Cancer
Volume 15 - 2025 | doi: 10.3389/fonc.2025.1561599
This article is part of the Research TopicAdvancing Breast Cancer Care Through Transparent AI and Federated Learning: Integrating Radiological, Histopathological, and Clinical Data for Diagnosis, Recurrence Prediction, and SurvivorshipView all 5 articles
Intra- and Peritumoral Radiomics Nomogram Based on DCE-MRI for the Early Prediction of Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer
Provisionally accepted- 1Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, Anhui, China
- 2Department of Radiology, Anhui No.2 Provincial People's Hospital, Hefei, China
- 3Department of Medical Imaging Diagnostics, Bengbu Medical University, Bengbu, China
- 4Department of Clinical Medicine, Bengbu Medical College, Bengbu, Anhui Province, China
- 5Zhongshan Hospital, Fudan University, Shanghai, Shanghai Municipality, China
Select one of your emails
You have multiple emails registered with Frontiers:
Notify me on publication
Please enter your email address:
If you already have an account, please login
You don't have a Frontiers account ? You can register here
Purpose: This study aimed to create a nomogram model (NM) that combines clinical-radiological factors with radiomics features of both intra- and peritumoral regions extracted from pretherapy dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) images, in order to establish a reliable method for early prediction of pathological complete response (pCR) to neoadjuvant chemotherapy (NAC) in patients with breast cancer.Methods: A total of 214 patients were randomly divided into a training set (n=149) and a test set (n=65) in a ratio of 7:3. Radiomics features were extracted from intratumoral region and 2-mm, 4-mm, 6-mm, 8-mm peritumoral regions on DCE-MRI images , and selected the optimal peritumoral region. The intratumoral radiomics model (IRM), 2-mm, 4-mm, 6-mm, 8-mm peritumoral radiomics model (PRM), the combined intra- and the optimal peritumoral radiomics model (CIPRM) were constructed based on five machine learning algorithms, and then the radiomics scores (Rad-score) were obtained. Independent risk factors for clinical-radiological features were obtained by univariate and multivariate logistic regression analysis, and clinical model (CM) was constructed. Finally, the CIPRM Rad-score combined with clinical-radiological factors was used to construct a NM. The performance of different models were evaluated by receiver operating characteristic curve (ROC) analysis, calibration curve analysis, and decision curve analysis (DCA).Results: In our study, the 6-mm peritumoral size was considered to be the optimal peritumoral region. The CM is constructed based on three independent risk factors: estrogen receptor (ER), Ki67, and breast edema score (BES). Incorporating ER, Ki-67, BES, and CIPRM Rad-score (combined intra- and 6-mm peritumoral) into the nomogram achieved a reliable predictive performance. And the area under the curve (AUC), sensitivity, specificity, and accuracy of the NM was 0.911, 0.848, 0.831, 0.826 for the training set and 0.897, 0.893, 0.784 , 0.815 for the test set, respectively.Conclusion: The NM has a good value for early prediction of pCR after NAC in breast cancer patients.
Keywords: breast cancer, Neoadjuvant chemotherapy, Pathological complete response, Intratumoral, Peritumoral, Radiomics, nomogram
Received: 16 Jan 2025; Accepted: 15 May 2025.
Copyright: © 2025 Zhu, Zhang, Wei, Yang, Wang, Wang, Fan, Sun and Xie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Haitao Sun, Zhongshan Hospital, Fudan University, Shanghai, 200032, Shanghai Municipality, China
Zongyu Xie, Department of Radiology, The First Affiliated Hospital of Bengbu Medical College, Bengbu, 233004, Anhui, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.